Enbrel Deceleration Continues: Firm Cites End Of Oral Demo As New Speed Bump

The firm recently begun a rheumatology ad campaign for TNF inhibitor etanercept; a dermatology television ad is yet to come.

More from Archive

More from Pink Sheet